ZNF670
gene geneOn this page
Also known as MGC12466
Summary
ZNF670 (zinc finger protein 670, HGNC:28167) is a protein-coding gene on chromosome 1q44, encoding Zinc finger protein 670 (Q9BS34). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Acts upstream of or within lipid metabolic process. Predicted to be active in nucleus.
Source: NCBI Gene 93474 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 60 total
- MANE Select transcript:
NM_033213
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28167 |
| Approved symbol | ZNF670 |
| Name | zinc finger protein 670 |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC12466 |
| Ensembl gene | ENSG00000277462 |
| Ensembl biotype | protein_coding |
| Entrez | 93474 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000366503, ENST00000908465, ENST00000908466
RefSeq mRNA: 2 — MANE Select: NM_033213
NM_001204220, NM_033213
CCDS: CCDS31087
Canonical transcript exons
ENST00000366503 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000961401 | 247034637 | 247038427 |
| ENSE00001441870 | 247078594 | 247078811 |
| ENSE00002344844 | 247038810 | 247038870 |
| ENSE00002373108 | 247039411 | 247039537 |
Expression profiles
Bgee: expression breadth ubiquitous, 178 present calls, max score 82.37.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5911 / max 68.3181, expressed in 1351 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 18498 | 3.5911 | 1351 |
| 18499 | 0.8772 | 520 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 82.37 | gold quality |
| sperm | CL:0000019 | 81.27 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.86 | gold quality |
| secondary oocyte | CL:0000655 | 78.73 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.63 | gold quality |
| ganglionic eminence | UBERON:0004023 | 78.52 | gold quality |
| ventricular zone | UBERON:0003053 | 74.70 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 72.29 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 71.30 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 71.24 | silver quality |
| islet of Langerhans | UBERON:0000006 | 70.83 | gold quality |
| stromal cell of endometrium | CL:0002255 | 69.44 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 68.30 | gold quality |
| primary visual cortex | UBERON:0002436 | 67.99 | gold quality |
| cerebellar cortex | UBERON:0002129 | 67.69 | gold quality |
| cerebellum | UBERON:0002037 | 67.63 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 67.57 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 66.89 | gold quality |
| oocyte | CL:0000023 | 66.51 | silver quality |
| cartilage tissue | UBERON:0002418 | 66.40 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 66.04 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 65.90 | gold quality |
| occipital lobe | UBERON:0002021 | 65.51 | gold quality |
| body of uterus | UBERON:0009853 | 65.37 | gold quality |
| prefrontal cortex | UBERON:0000451 | 65.24 | gold quality |
| lymph node | UBERON:0000029 | 64.82 | gold quality |
| rectum | UBERON:0001052 | 64.74 | gold quality |
| gall bladder | UBERON:0002110 | 64.73 | gold quality |
| pancreas | UBERON:0001264 | 64.65 | gold quality |
| endometrium | UBERON:0001295 | 64.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.29 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
105 targeting ZNF670, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-8087 | 99.90 | 69.55 | 1351 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
Cross-species orthologs
0 orthologs
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391)
Protein
Protein identifiers
Zinc finger protein 670 — Q9BS34 (reviewed: Q9BS34)
All UniProt accessions (1): Q9BS34
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001191149, NP_149990* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465
UniProt features (12 total): zinc finger region 9, chain 1, domain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BS34-F1 | 68.20 | 0.26 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 281
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 53 (showing top):
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP, GOBP_LIPID_METABOLIC_PROCESS, chr1q44, GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, JOHNSTONE_PARVB_TARGETS_3_DN, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN, PCGF1_TARGET_GENES, SNIP1_TARGET_GENES, ZNF350_TARGET_GENES, ZNF597_TARGET_GENES
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), lipid metabolic process (GO:0006629), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| primary metabolic process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
224 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF670 | TBC1D3G | Q6DHY5 | 474 |
| ZNF670 | SH3BP5L | Q7L8J4 | 398 |
| ZNF670 | TBC1D3H | P0C7X1 | 348 |
| ZNF670 | PIGW | Q7Z7B1 | 316 |
| ZNF670 | TBC1D3D | A0A087WVF3 | 305 |
| ZNF670 | ZNHIT3 | Q15649 | 305 |
| ZNF670 | DDX52 | Q9Y2R4 | 297 |
| ZNF670 | TADA2A | O75478 | 295 |
| ZNF670 | STRN3 | Q13033 | 288 |
| ZNF670 | PAFAH1B3 | Q15102 | 285 |
| ZNF670 | LRRC8C | Q8TDW0 | 272 |
| ZNF670 | TFB2M | Q9H5Q4 | 258 |
| ZNF670 | PTGDS | P41222 | 257 |
| ZNF670 | A0A087WT91 | A0A087WT91 | 248 |
| ZNF670 | C17orf78 | Q8N4C9 | 244 |
IntAct
91 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF670 | CCNDBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF670 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF670 | OPTN | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM41 | ZNF670 | psi-mi:“MI:0915”(physical association) | 0.720 |
| OPTN | ZNF670 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CCNDBP1 | ZNF670 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF670 | MDFI | psi-mi:“MI:0915”(physical association) | 0.700 |
| MDFI | ZNF670 | psi-mi:“MI:0915”(physical association) | 0.700 |
| CSNK2A2 | ZNF670 | psi-mi:“MI:0915”(physical association) | 0.670 |
| KRTAP10-5 | ZNF670 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF670 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF670 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10 | ZNF670 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF670 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF670 | KRTAP10-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF670 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | ZNF670 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (32): ZNF670 (Two-hybrid), ZNF670 (Two-hybrid), ZNF670 (Two-hybrid), ZNF670 (Two-hybrid), ZNF670 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-3 (Two-hybrid), ZNF670 (Two-hybrid), ZNF670 (Two-hybrid), ZNF670 (Proximity Label-MS), ZNF670 (Two-hybrid), ZNF670 (Two-hybrid), ZNF670 (Two-hybrid), ZNF670 (Two-hybrid)
ESM2 similar proteins: A1L1L7, A2VDP4, A6NHJ4, D3ZVT0, E9PW05, O60765, P08042, P17014, P18723, P52738, P85977, Q02975, Q06730, Q0VGE8, Q2KI58, Q2M3W8, Q2TL60, Q2VY69, Q3MIS6, Q4V8A8, Q5R4K8, Q5VIY5, Q61751, Q61967, Q6GQR8, Q6P2D0, Q6PF04, Q7L2R6, Q7Z3I7, Q86Y25, Q8BFS8, Q8BQC8, Q8BZ89, Q8N184, Q8N782, Q8N823, Q8N8J6, Q8R1D1, Q8TF47, Q8WTR7
Diamond homologs: A0JPK3, A2RRD8, A2VDQ7, A3KN32, A8MUZ8, A8MWA4, C9JN71, E9QAG8, O60384, O60765, O75820, P0CH99, P0CI00, P10076, P10755, P15621, P16374, P16415, P17017, P17024, P51523, P52737, P52740, Q06730, Q06732, Q08AG5, Q0D2J5, Q13106, Q13360, Q15928, Q15935, Q15973, Q32M78, Q3KP31, Q4R4C7, Q4R6J4, Q4R882, Q5R9F0, Q5RC79, Q5REI6
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 32 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| DNA damage response | 6 | 11.5× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
60 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 57 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
648 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:247038425:CTG:C | acceptor_gain | 1.0000 |
| 1:247038805:ATTAC:A | donor_loss | 1.0000 |
| 1:247038806:TTACC:T | donor_loss | 1.0000 |
| 1:247038807:TACC:T | donor_loss | 1.0000 |
| 1:247038808:ACCT:A | donor_loss | 1.0000 |
| 1:247038809:C:CT | donor_loss | 1.0000 |
| 1:247038868:TTC:T | acceptor_gain | 1.0000 |
| 1:247038869:TC:T | acceptor_gain | 1.0000 |
| 1:247038869:TCCTA:T | acceptor_loss | 1.0000 |
| 1:247038870:CC:C | acceptor_gain | 1.0000 |
| 1:247038870:CCTAA:C | acceptor_loss | 1.0000 |
| 1:247038871:C:CC | acceptor_gain | 1.0000 |
| 1:247038871:CTAAA:C | acceptor_loss | 1.0000 |
| 1:247038872:T:C | acceptor_loss | 1.0000 |
| 1:247038878:G:C | acceptor_gain | 1.0000 |
| 1:247038878:G:GC | acceptor_gain | 1.0000 |
| 1:247039405:TCTTA:T | donor_loss | 1.0000 |
| 1:247039406:CTTA:C | donor_loss | 1.0000 |
| 1:247039407:TTAC:T | donor_loss | 1.0000 |
| 1:247039408:TA:T | donor_loss | 1.0000 |
| 1:247039410:C:A | donor_loss | 1.0000 |
| 1:247039410:CCTA:C | donor_gain | 1.0000 |
| 1:247039547:C:CT | acceptor_gain | 1.0000 |
| 1:247039551:CATA:C | acceptor_gain | 1.0000 |
| 1:247039552:A:C | acceptor_gain | 1.0000 |
| 1:247039554:A:C | acceptor_gain | 1.0000 |
| 1:247078591:CACC:C | donor_loss | 1.0000 |
| 1:247038423:GACTG:G | acceptor_gain | 0.9900 |
| 1:247038426:TG:T | acceptor_gain | 0.9900 |
| 1:247038428:C:CC | acceptor_gain | 0.9900 |
AlphaMissense
2594 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:247037833:G:C | F262L | 0.996 |
| 1:247037833:G:T | F262L | 0.996 |
| 1:247037835:A:G | F262L | 0.996 |
| 1:247037917:G:C | F234L | 0.993 |
| 1:247037917:G:T | F234L | 0.993 |
| 1:247037919:A:G | F234L | 0.993 |
| 1:247037749:A:C | F290L | 0.992 |
| 1:247037749:A:T | F290L | 0.992 |
| 1:247037751:A:G | F290L | 0.992 |
| 1:247037665:G:C | F318L | 0.990 |
| 1:247037665:G:T | F318L | 0.990 |
| 1:247037667:A:G | F318L | 0.990 |
| 1:247037581:A:C | F346L | 0.989 |
| 1:247037581:A:T | F346L | 0.989 |
| 1:247037583:A:G | F346L | 0.989 |
| 1:247038001:G:C | F206L | 0.989 |
| 1:247038001:G:T | F206L | 0.989 |
| 1:247038003:A:G | F206L | 0.989 |
| 1:247037497:G:C | F374L | 0.986 |
| 1:247037497:G:T | F374L | 0.986 |
| 1:247037499:A:G | F374L | 0.986 |
| 1:247037828:C:G | R264P | 0.986 |
| 1:247037878:A:C | H247Q | 0.983 |
| 1:247037878:A:T | H247Q | 0.983 |
| 1:247037962:A:C | H219Q | 0.983 |
| 1:247037962:A:T | H219Q | 0.983 |
| 1:247037834:A:G | F262S | 0.979 |
| 1:247037890:A:C | H243Q | 0.976 |
| 1:247037890:A:T | H243Q | 0.976 |
| 1:247037900:A:G | L240P | 0.976 |
dbSNP variants (sampled 300 via entrez): RS1000024522 (1:247036897 C>A), RS1000025141 (1:247073649 A>T), RS1000083209 (1:247041219 G>T), RS1000085854 (1:247078928 G>A), RS1000220611 (1:247047573 G>C), RS1000268047 (1:247078775 G>A), RS1000369684 (1:247050006 T>A,C), RS1000380833 (1:247071864 T>TC), RS1000429722 (1:247064623 T>G), RS1000443679 (1:247050357 T>C), RS1000558391 (1:247054006 T>C,G), RS1000639158 (1:247066492 G>A), RS1000692248 (1:247042471 T>C,G), RS1000704246 (1:247048555 G>A), RS1000759629 (1:247064916 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001692_1 | Response to taxane treatment (docetaxel) | 2.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
30 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | increases abundance, increases palmitoylation, increases expression, decreases reaction | 3 |
| methylmercuric chloride | increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| 2-bromopalmitate | decreases reaction, increases abundance, increases palmitoylation | 1 |
| avobenzone | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression, affects cotreatment | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Arbutin | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases reaction, increases abundance, increases palmitoylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Dinitrofluorobenzene | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Oxazolone | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Aflatoxin M1 | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW75 | HEK293 eGFP-ZNF670 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.